The Health-System Pharmacist Role in Optimizing Outcomes for Patients Who Need DOAC Reversal Agents

FACULTY

James S. Kalus, PharmD, FASHP Director of Pharmacy Henry Ford Health System Detroit, Michigan

EDUCATIONAL OBJECTIVES

At the completion of this activity the participant will be able to:

• Analyze the unaddressed gaps of reversal agents for direct oral anticoagulants (DOACs) and the risk of bleeding complications
• Identify patients who are at high risk for major bleeding secondary to DOAC use
• Examine current and emerging DOAC reversal agents and their safety and efficacy
• Explore the role of the health-system pharmacist in ensuring optimal management of the patient with DOAC-associated bleeding and implementing standards of practice for reversal agents using clinical vignettes

TARGET AUDIENCE: Health-system pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: March 15, 2019

EXPIRATION DATE: March 15, 2020

ESTIMATED TIME TO COMPLETE ACTIVITY: 2 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.